Drug-class overview:@0.657199:0.039086:0.902803:0.039086:0.902803:0.019651:0.657199:0.019651:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
23:@0.950592:0.038665:0.976698:0.038665:0.976698:0.018632:0.950592:0.018632:0.000000:0.000000
Drug-class overview:@0.981851:0.292741:0.981851:0.109337:0.953582:0.109337:0.953582:0.292741:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
MIMS ConCISe GuIde to CardIovaSCular, MetabolIC and endoCrIne dISeaSeS :@0.216640:0.974259:0.820834:0.974259:0.820834:0.960936:0.216640:0.960936:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.820834:0.974259:0.824580:0.974259:0.824580:0.960936:0.820834:0.960936:0.000000
VOLUME 1:@0.824751:0.974259:0.906065:0.974259:0.906065:0.959690:0.824751:0.959690:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
by  response.  alternatively,  in  combination  with :@0.096970:0.096562:0.479951:0.096562:0.479951:0.081574:0.096970:0.081574:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
low-dose hydrochlorothiazide (12.5 mg).  the :@0.096970:0.111683:0.479970:0.111683:0.479970:0.096695:0.096970:0.096695:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
maximum antihypertensive effect is attained :@0.096970:0.126804:0.479970:0.126804:0.479970:0.111816:0.096970:0.111816:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
4-8 weeks after start of treatment :@0.096970:0.142216:0.355337:0.142216:0.355337:0.127228:0.096970:0.127228:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Contraindications::@0.096970:0.162100:0.254757:0.162100:0.254757:0.145709:0.096970:0.145709:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
5:@0.254755:0.156323:0.260981:0.156323:0.260981:0.146768:0.254755:0.146768:0.000000
Severely  impaired  renal  and  hepatic  function :@0.096970:0.177526:0.479932:0.177526:0.479932:0.162538:0.096970:0.162538:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.096970:0.192422:0.105783:0.192422:0.105783:0.177738:0.096970:0.177738:0.000000
 Pregnancy and lactation   Children    renal :@0.105783:0.192938:0.479970:0.192938:0.479970:0.177950:0.105783:0.177950:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.321894:0.192422:0.330707:0.192422:0.330707:0.177738:0.321894:0.177738:0.000000
:@0.415008:0.192422:0.423821:0.192422:0.423821:0.177738:0.415008:0.177738:0.000000
artery stenosis    aortic stenosis   Hypertrophic :@0.096970:0.208350:0.479951:0.208350:0.479951:0.193362:0.096970:0.193362:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.218235:0.207834:0.227048:0.207834:0.227048:0.193150:0.218235:0.193150:0.000000
:@0.357146:0.207834:0.365959:0.207834:0.365959:0.193150:0.357146:0.193150:0.000000
obstructive cardiomyopathy    angio-oedema :@0.096950:0.223762:0.479951:0.223762:0.479951:0.208774:0.096950:0.208774:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.336691:0.223246:0.345504:0.223246:0.345504:0.208562:0.336691:0.208562:0.000000
:@0.096950:0.238658:0.105763:0.238658:0.105763:0.223974:0.096950:0.223974:0.000000
 Porphyria :@0.105763:0.239174:0.203630:0.239174:0.203630:0.224186:0.105763:0.224186:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.220082:0.238658:0.228895:0.238658:0.228895:0.223974:0.220082:0.223974:0.000000
 Concomitant lithium and  :@0.228895:0.239174:0.479951:0.239174:0.479951:0.224186:0.228895:0.224186:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
K -sparing diuretics   biliary obstruction disorders :@0.096950:0.254586:0.479960:0.254617:0.479960:0.239629:0.096950:0.239598:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
+:@0.106552:0.248833:0.113238:0.248833:0.113238:0.240095:0.106552:0.240095:0.000000
:@0.249782:0.254101:0.258595:0.254101:0.258595:0.239417:0.249782:0.239417:0.000000
:@0.096978:0.269513:0.105791:0.269513:0.105791:0.254829:0.096978:0.254829:0.000000
  angiotensin receptor blocker or  aCe-inhibitor :@0.105791:0.270029:0.479998:0.270029:0.479998:0.255041:0.105791:0.255041:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
exposure:@0.096998:0.285441:0.167636:0.285441:0.167636:0.270453:0.096998:0.270453:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Side effects::@0.096998:0.305325:0.200214:0.305325:0.200214:0.288934:0.096998:0.288934:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
5:@0.200184:0.299548:0.206411:0.299548:0.206411:0.289992:0.200184:0.289992:0.000000
Insomnia    depression   Syncope   Fainting :@0.096970:0.320751:0.479990:0.320751:0.479990:0.305762:0.096970:0.305762:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.179038:0.320235:0.187851:0.320235:0.187851:0.305551:0.179038:0.305551:0.000000
:@0.296417:0.320235:0.305230:0.320235:0.305230:0.305551:0.296417:0.305551:0.000000
:@0.394034:0.320235:0.402847:0.320235:0.402847:0.305551:0.394034:0.305551:0.000000
 :@0.475776:0.320751:0.479990:0.320751:0.479990:0.305762:0.475776:0.305762:0.000000
:@0.096989:0.335647:0.105802:0.335647:0.105802:0.320963:0.096989:0.320963:0.000000
 visual disturbances   bradycardia   tachycardia :@0.105802:0.336163:0.480009:0.336163:0.480009:0.321174:0.105802:0.321174:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.263955:0.335647:0.272768:0.335647:0.272768:0.320963:0.263955:0.320963:0.000000
:@0.372752:0.335647:0.381565:0.335647:0.381565:0.320963:0.372752:0.320963:0.000000
:@0.097008:0.351059:0.105821:0.351059:0.105821:0.336375:0.097008:0.336375:0.000000
 Hypotension    angio-oedema    back and :@0.105821:0.351575:0.480047:0.351575:0.480047:0.336586:0.105821:0.336586:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.228876:0.351059:0.237689:0.351059:0.237689:0.336375:0.228876:0.336375:0.000000
:@0.378197:0.351059:0.387010:0.351059:0.387010:0.336375:0.378197:0.336375:0.000000
chest pain   Myalgia    arthralgia    utI    urtI :@0.097027:0.366987:0.480047:0.366987:0.480047:0.351998:0.097027:0.351998:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.188429:0.366471:0.197242:0.366471:0.197242:0.351787:0.188429:0.351787:0.000000
:@0.273134:0.366471:0.281947:0.366471:0.281947:0.351787:0.273134:0.351787:0.000000
:@0.373560:0.366471:0.382373:0.366471:0.382373:0.351787:0.373560:0.351787:0.000000
:@0.423783:0.366471:0.432596:0.366471:0.432596:0.351787:0.423783:0.351787:0.000000
 :@0.475833:0.366987:0.480047:0.366987:0.480047:0.351998:0.475833:0.351998:0.000000
:@0.097047:0.381883:0.105860:0.381883:0.105860:0.367199:0.097047:0.367199:0.000000
 Hyperkalaemia    blood dyscrasia   Hyper-:@0.105860:0.382399:0.475833:0.382399:0.475833:0.367410:0.105860:0.367410:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.244482:0.381883:0.253295:0.381883:0.253295:0.367199:0.244482:0.367199:0.000000
:@0.402982:0.381883:0.411795:0.381883:0.411795:0.367199:0.402982:0.367199:0.000000
sensitivity reactions   abnormal hepatic function :@0.097047:0.397811:0.480067:0.397811:0.480067:0.382822:0.097047:0.382822:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.252564:0.397295:0.261377:0.397295:0.261377:0.382611:0.252564:0.382611:0.000000
:@0.097047:0.412707:0.105860:0.412707:0.105860:0.398023:0.097047:0.398023:0.000000
  rash   Skin reactions    eczema    erythema :@0.105860:0.413223:0.480067:0.413223:0.480067:0.398234:0.105860:0.398234:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.160277:0.412707:0.169090:0.412707:0.169090:0.398023:0.160277:0.398023:0.000000
:@0.298245:0.412707:0.307058:0.412707:0.307058:0.398023:0.298245:0.398023:0.000000
:@0.384162:0.412707:0.392975:0.412707:0.392975:0.398023:0.384162:0.398023:0.000000
:@0.097066:0.428119:0.105879:0.428119:0.105879:0.413435:0.097066:0.413435:0.000000
  urticaria   Pruritis    leg cramps    vertigo :@0.105879:0.428635:0.480086:0.428635:0.480086:0.413646:0.105879:0.413646:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.191931:0.428119:0.200744:0.428119:0.200744:0.413435:0.191931:0.413435:0.000000
:@0.274846:0.428119:0.283659:0.428119:0.283659:0.413435:0.274846:0.413435:0.000000
:@0.401269:0.428119:0.410082:0.428119:0.410082:0.413435:0.401269:0.413435:0.000000
 :@0.475872:0.428635:0.480086:0.428635:0.480086:0.413646:0.475872:0.413646:0.000000
:@0.097085:0.443531:0.105898:0.443531:0.105898:0.428846:0.097085:0.428846:0.000000
  dyspnoea    dry mouth   Sweating    renal :@0.105898:0.444047:0.480105:0.444047:0.480105:0.429058:0.105898:0.429058:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.201687:0.443531:0.210500:0.443531:0.210500:0.428846:0.201687:0.428846:0.000000
:@0.317334:0.443531:0.326147:0.443531:0.326147:0.428846:0.317334:0.428846:0.000000
:@0.415758:0.443531:0.424571:0.443531:0.424571:0.428846:0.415758:0.428846:0.000000
impairment  and  acute  renal  failure    Weakness :@0.097104:0.459459:0.480105:0.459459:0.480105:0.444470:0.097104:0.444470:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.383951:0.458943:0.392764:0.458943:0.392764:0.444258:0.383951:0.444258:0.000000
 :@0.475891:0.459459:0.480105:0.459459:0.480105:0.444470:0.475891:0.444470:0.000000
:@0.097104:0.474355:0.105917:0.474355:0.105917:0.459670:0.097104:0.459670:0.000000
 Flu-like symptoms:@0.105917:0.474871:0.249735:0.474871:0.249735:0.459882:0.105917:0.459882:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Special precautions::@0.097104:0.494754:0.269535:0.494754:0.269535:0.478363:0.097104:0.478363:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
5:@0.269398:0.489027:0.275624:0.489027:0.275624:0.479471:0.269398:0.479471:0.000000
Monitor serum K  and creatinine levels in severely :@0.096970:0.510230:0.479990:0.510230:0.479990:0.495241:0.096970:0.495241:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
+:@0.224308:0.504446:0.230994:0.504446:0.230994:0.495707:0.224308:0.495707:0.000000
impaired renal function   Monitor plasma digoxin :@0.096970:0.525642:0.479990:0.525642:0.479990:0.510653:0.096970:0.510653:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.280504:0.525126:0.289317:0.525126:0.289317:0.510442:0.280504:0.510442:0.000000
and lithium levels   antihypertensive effects less :@0.096970:0.541054:0.480010:0.541054:0.480010:0.526065:0.096970:0.526065:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.240576:0.540538:0.249389:0.540538:0.249389:0.525854:0.240576:0.525854:0.000000
in black patients    discontinue immediately in :@0.096970:0.556466:0.479990:0.556466:0.479990:0.541477:0.096970:0.541477:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.238902:0.555950:0.247715:0.555950:0.247715:0.541266:0.238902:0.541266:0.000000
pregnancy   Salt- and volume-depleted patients :@0.096970:0.571878:0.479952:0.571878:0.479952:0.556889:0.096970:0.556889:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.185139:0.571362:0.193952:0.571362:0.193952:0.556678:0.185139:0.556678:0.000000
:@0.096970:0.586774:0.105783:0.586774:0.105783:0.572090:0.096970:0.572090:0.000000
 renal arterial stenosis   Primary aldosteronism :@0.105783:0.587290:0.479971:0.587290:0.479971:0.572301:0.105783:0.572301:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.287220:0.586774:0.296033:0.586774:0.296033:0.572090:0.287220:0.572090:0.000000
:@0.096970:0.602186:0.105783:0.602186:0.105783:0.587502:0.096970:0.587502:0.000000
 aortic or mitral stenosis   Hepatic impairment :@0.105783:0.602702:0.479971:0.602702:0.479971:0.587713:0.105783:0.587713:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.304673:0.602186:0.313486:0.602186:0.313486:0.587502:0.304673:0.587502:0.000000
:@0.096970:0.617598:0.105783:0.617598:0.105783:0.602914:0.096970:0.602914:0.000000
  biliary obstruction disorders    obstructive :@0.105783:0.618114:0.479971:0.618114:0.479971:0.603125:0.105783:0.603125:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.364247:0.617598:0.373060:0.617598:0.373060:0.602914:0.364247:0.602914:0.000000
hypertrophic cardiomyopathy   Concomitant :@0.096970:0.633526:0.479971:0.633526:0.479971:0.618537:0.096970:0.618537:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.351470:0.633010:0.360283:0.633010:0.360283:0.618326:0.351470:0.618326:0.000000
nSaIds   Concomitant  medication that  affects :@0.096970:0.648938:0.479971:0.648938:0.479971:0.633949:0.096970:0.633949:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.161990:0.648422:0.170803:0.648422:0.170803:0.633738:0.161990:0.633738:0.000000
the:@0.096970:0.664350:0.122563:0.664350:0.122563:0.649361:0.096970:0.649361:0.000000:0.000000:0.000000
renin-angiotensin-aldosterone:@0.155929:0.664350:0.388666:0.664350:0.388666:0.649361:0.155929:0.649361:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
system :@0.422032:0.664350:0.479971:0.664350:0.479971:0.649361:0.422032:0.649361:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.096970:0.679246:0.105783:0.679246:0.105783:0.664562:0.096970:0.664562:0.000000
  K -sparing  diuretics,  K   supplementation,  K  :@0.105783:0.679762:0.479971:0.679831:0.479971:0.664842:0.105783:0.664773:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
+:@0.126141:0.674046:0.132827:0.674046:0.132827:0.665308:0.126141:0.665308:0.000000
+:@0.295230:0.674046:0.301916:0.674046:0.301916:0.665308:0.295230:0.665308:0.000000
+:@0.469071:0.674046:0.475757:0.674046:0.475757:0.665308:0.469071:0.665308:0.000000
salts or drugs increasing K  level   Ischaemic :@0.096970:0.695242:0.479963:0.695249:0.479963:0.680260:0.096970:0.680254:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
+:@0.318145:0.689464:0.324831:0.689464:0.324831:0.680726:0.318145:0.680726:0.000000
:@0.380345:0.694733:0.389158:0.694733:0.389158:0.680048:0.380345:0.680048:0.000000
cardiomyopathy or Cv disease:@0.096962:0.710661:0.328333:0.710661:0.328333:0.695672:0.096962:0.695672:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Drug interactions::@0.096962:0.730544:0.251922:0.730544:0.251922:0.714153:0.096962:0.714153:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
5:@0.251927:0.724761:0.258153:0.724761:0.258153:0.715205:0.251927:0.715205:0.000000
Concomitant antihypertensives    digoxin    li-:@0.096970:0.745964:0.475756:0.745964:0.475756:0.730975:0.096970:0.730975:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.352105:0.745448:0.360918:0.745448:0.360918:0.730764:0.352105:0.730764:0.000000
:@0.439215:0.745448:0.448028:0.745448:0.448028:0.730764:0.439215:0.730764:0.000000
thium   nSaIds:@0.096970:0.761376:0.216600:0.761376:0.216600:0.746387:0.096970:0.746387:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.147442:0.760860:0.156255:0.760860:0.156255:0.746176:0.147442:0.746176:0.000000
valsartan:@0.096970:0.789543:0.192525:0.789543:0.192525:0.769785:0.096970:0.769785:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Indications::@0.096970:0.808687:0.197357:0.808687:0.197357:0.792296:0.096970:0.792296:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
5:@0.197355:0.802903:0.203582:0.802903:0.203582:0.793347:0.197355:0.793347:0.000000
Mild to moderate hypertension:@0.096970:0.824106:0.336845:0.824106:0.336845:0.809117:0.096970:0.809117:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Dosage: :@0.096970:0.843989:0.170283:0.843989:0.170283:0.827598:0.096970:0.827598:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
recommended dose: 80 mg once daily. :@0.096970:0.859401:0.479970:0.859401:0.479970:0.844412:0.096970:0.844412:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Substantial effect presents within 2 weeks; :@0.096970:0.874813:0.480009:0.874813:0.480009:0.859824:0.096970:0.859824:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Maximum effect after 4 weeks. the dose may be :@0.096970:0.890225:0.479990:0.890225:0.479990:0.875236:0.096970:0.875236:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
increased to 160 mg daily or a diuretic may be :@0.096970:0.905637:0.479913:0.905637:0.479913:0.890648:0.096970:0.890648:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
added in patients not adequately controlled with :@0.096970:0.921049:0.479951:0.921049:0.479951:0.906060:0.096970:0.906060:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
other antihypertensives.:@0.096970:0.936620:0.281312:0.936620:0.281312:0.921631:0.096970:0.921631:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Contraindications::@0.524247:0.096541:0.682035:0.096541:0.682035:0.080150:0.524247:0.080150:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
5:@0.682028:0.090778:0.688254:0.090778:0.688254:0.081222:0.682028:0.081222:0.000000
Pregnancy :@0.524242:0.111899:0.609601:0.111899:0.609601:0.096910:0.524242:0.096910:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.620820:0.111383:0.629633:0.111383:0.629633:0.096699:0.620820:0.096699:0.000000
  lactation :@0.629633:0.111899:0.720630:0.111899:0.720630:0.096910:0.629633:0.096910:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.731848:0.111383:0.740661:0.111383:0.740661:0.096699:0.731848:0.096699:0.000000
 Children :@0.740661:0.111899:0.825270:0.111899:0.825270:0.096910:0.740661:0.096910:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.836489:0.111383:0.845302:0.111383:0.845302:0.096699:0.836489:0.096699:0.000000
  renal :@0.845321:0.111899:0.907243:0.111899:0.907243:0.096910:0.845321:0.096910:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
impairment:@0.524242:0.127232:0.614566:0.127232:0.614566:0.112243:0.524242:0.112243:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Side effects::@0.524242:0.147022:0.627458:0.147022:0.627458:0.130631:0.524242:0.130631:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
5:@0.627457:0.141248:0.633683:0.141248:0.633683:0.131692:0.627457:0.131692:0.000000
Hypotension   CnS effects    viral  infections :@0.524242:0.162369:0.907262:0.162369:0.907262:0.147380:0.524242:0.147380:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.635348:0.161853:0.644161:0.161853:0.644161:0.147168:0.635348:0.147168:0.000000
:@0.763541:0.161853:0.772354:0.161853:0.772354:0.147168:0.763541:0.147168:0.000000
:@0.524261:0.177185:0.533074:0.177185:0.533074:0.162501:0.524261:0.162501:0.000000
  utI   Cough   GI disturbances    rhinitis, :@0.533074:0.177701:0.907281:0.177701:0.907281:0.162713:0.533074:0.162713:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.581411:0.177185:0.590224:0.177185:0.590224:0.162501:0.581411:0.162501:0.000000
:@0.665577:0.177185:0.674390:0.177185:0.674390:0.162501:0.665577:0.162501:0.000000
:@0.823789:0.177185:0.832602:0.177185:0.832602:0.162501:0.823789:0.162501:0.000000
sinusitis    back  pain    Pharyngitis    arthralgia :@0.524280:0.193034:0.907320:0.193034:0.907320:0.178045:0.524280:0.178045:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.593361:0.192518:0.602174:0.192518:0.602174:0.177834:0.593361:0.177834:0.000000
:@0.698097:0.192518:0.706910:0.192518:0.706910:0.177834:0.698097:0.177834:0.000000
:@0.810011:0.192518:0.818824:0.192518:0.818824:0.177834:0.810011:0.177834:0.000000
 :@0.903106:0.193034:0.907320:0.193034:0.907320:0.178045:0.903106:0.178045:0.000000
:@0.524319:0.207851:0.533132:0.207851:0.533132:0.193166:0.524319:0.193166:0.000000
 oedema   decrease in libido   Hypersensitivity :@0.533132:0.208367:0.907320:0.208367:0.907320:0.193378:0.533132:0.193378:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.609948:0.207851:0.618761:0.207851:0.618761:0.193166:0.609948:0.193166:0.000000
:@0.767389:0.207851:0.776202:0.207851:0.776202:0.193166:0.767389:0.193166:0.000000
reactions   Cardiac failure   Hypotension   renal :@0.524319:0.223699:0.907320:0.223699:0.907320:0.208711:0.524319:0.208711:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.599672:0.223183:0.608485:0.223183:0.608485:0.208499:0.599672:0.208499:0.000000
:@0.728269:0.223183:0.737082:0.223183:0.737082:0.208499:0.728269:0.208499:0.000000
:@0.846687:0.223183:0.855500:0.223183:0.855500:0.208499:0.846687:0.208499:0.000000
impairment   Fatigue   asthenia   decrease Hb :@0.524319:0.239032:0.907320:0.239032:0.907320:0.224043:0.524319:0.224043:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.621051:0.238516:0.629864:0.238516:0.629864:0.223831:0.621051:0.223831:0.000000
:@0.699348:0.238516:0.708161:0.238516:0.708161:0.223831:0.699348:0.223831:0.000000
:@0.787921:0.238516:0.796734:0.238516:0.796734:0.223831:0.787921:0.223831:0.000000
and haematocrit   neutropenia:@0.524319:0.254364:0.765080:0.254364:0.765080:0.239376:0.524319:0.239376:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.655571:0.253848:0.664384:0.253848:0.664384:0.239164:0.655571:0.239164:0.000000
Special precautions: :@0.524319:0.274155:0.700637:0.274155:0.700637:0.257764:0.524319:0.257764:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
5:@0.700557:0.268399:0.706784:0.268399:0.706784:0.258844:0.700557:0.258844:0.000000
teratogenicity reported in experimental animals :@0.524242:0.289520:0.907262:0.289520:0.907262:0.274532:0.524242:0.274532:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.524242:0.304337:0.533055:0.304337:0.533055:0.289653:0.524242:0.289653:0.000000
 Salt- and volume-depleted patients   Monitor :@0.533055:0.304853:0.907243:0.304853:0.907243:0.289864:0.533055:0.289864:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.826021:0.304337:0.834834:0.304337:0.834834:0.289653:0.826021:0.289653:0.000000
blood urea and serum creatinine in patients with :@0.524242:0.320186:0.907224:0.320186:0.907224:0.305197:0.524242:0.305197:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
renal artery stenosis    access renal function in :@0.524242:0.335518:0.907262:0.335518:0.907262:0.320530:0.524242:0.320530:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.692652:0.335002:0.701465:0.335002:0.701465:0.320318:0.692652:0.320318:0.000000
post-MI and HF patients:@0.524242:0.350851:0.708103:0.350851:0.708103:0.335862:0.524242:0.335862:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Drug interactions::@0.524242:0.370642:0.679201:0.370642:0.679201:0.354251:0.524242:0.354251:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
5:@0.679199:0.364879:0.685425:0.364879:0.685425:0.355323:0.679199:0.355323:0.000000
K -sparing diuretics, K  supplementation, K  salts :@0.524242:0.385999:0.907248:0.385999:0.907248:0.371011:0.524242:0.371011:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
+:@0.533824:0.380215:0.540510:0.380215:0.540510:0.371477:0.533824:0.371477:0.000000
+:@0.693189:0.380215:0.699875:0.380215:0.699875:0.371477:0.693189:0.371477:0.000000
+:@0.857305:0.380215:0.863991:0.380215:0.863991:0.371477:0.857305:0.371477:0.000000
or drugs increasing K level :@0.524248:0.401332:0.733638:0.401336:0.733638:0.386347:0.524248:0.386343:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
+ :@0.684818:0.395551:0.693960:0.395551:0.693960:0.386813:0.684818:0.386813:0.000000:0.000000
REfEREnCES:@0.524435:0.432014:0.637080:0.432014:0.637080:0.415623:0.524435:0.415623:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
1.   World Health  organisation ISoHWG. 2003  World :@0.524242:0.445655:0.906815:0.445655:0.906815:0.432331:0.524242:0.432331:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Health organization (WHo)/International Society of :@0.554551:0.459672:0.906781:0.459672:0.906781:0.446348:0.554551:0.446348:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Hypertension (ISH) statement on the management :@0.554551:0.473689:0.906764:0.473689:0.906764:0.460365:0.554551:0.460365:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
of:@0.554551:0.487706:0.568132:0.487706:0.568132:0.474382:0.554551:0.474382:0.000000:0.000000
hypertension.:@0.592796:0.487706:0.686391:0.487706:0.686391:0.474382:0.592796:0.474382:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Journal:@0.711056:0.487706:0.760043:0.487706:0.760043:0.474618:0.711056:0.474618:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
of:@0.780311:0.487706:0.793225:0.487706:0.793225:0.474618:0.780311:0.474618:0.000000:0.000000
Hypertension.:@0.813494:0.487706:0.903052:0.487706:0.903052:0.474618:0.813494:0.474618:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.903052:0.487706:0.906798:0.487706:0.906798:0.474382:0.903052:0.474382:0.000000
2003;21:1983-92.:@0.554551:0.501723:0.668740:0.501723:0.668740:0.488399:0.554551:0.488399:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
2.   Head Ga, Chan CKS, burke Sl. relationship between :@0.524242:0.515740:0.906781:0.515740:0.906781:0.502417:0.524242:0.502417:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
imidazoline and α2-adrenoceptors involved in the :@0.554551:0.529757:0.906798:0.529757:0.906798:0.516434:0.554551:0.516434:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
sympatho-inhibitory  actions of  centrally  acting :@0.554551:0.543774:0.906764:0.543774:0.906764:0.530451:0.554551:0.530451:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
antihypertensive agents. :@0.554551:0.557791:0.727938:0.557791:0.727938:0.544468:0.554551:0.544468:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Journal of the Autonomic :@0.730794:0.557791:0.906080:0.557791:0.906080:0.544703:0.730794:0.544703:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Nervous System.:@0.554551:0.571808:0.659999:0.571808:0.659999:0.558720:0.554551:0.558720:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 1998;72(2-3):163-9.:@0.659999:0.571808:0.792096:0.571808:0.792096:0.558485:0.659999:0.558485:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
3.   Krishnachetty  b,  Plaat F.  the  treatment  of :@0.524242:0.585825:0.906764:0.585825:0.906764:0.572502:0.524242:0.572502:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
hypertension in pregnancy. :@0.554551:0.599842:0.771058:0.599842:0.771058:0.586519:0.554551:0.586519:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Anaesthesia and :@0.784143:0.599842:0.906097:0.599842:0.906097:0.586754:0.784143:0.586754:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Intensive Care Medicine.:@0.554551:0.613859:0.709431:0.613859:0.709431:0.600771:0.554551:0.600771:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 2011;12(3):116-9.:@0.709431:0.613859:0.828084:0.613859:0.828084:0.600536:0.709431:0.600536:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
4.   nijkamp FP, de Jong W. Centrally induced hypotension :@0.524242:0.627876:0.906952:0.627876:0.906952:0.614553:0.524242:0.614553:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
by  α-methyldopa  and α-methylnoradrenaline  in :@0.554534:0.641893:0.906747:0.641893:0.906747:0.628570:0.554534:0.628570:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
normotensive and renal hypertensive rats. In: de :@0.554534:0.655910:0.906747:0.655910:0.906747:0.642587:0.554534:0.642587:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Jong  W, Provoost  aP and Shapiro  aP, editors. :@0.554534:0.669927:0.906798:0.669927:0.906798:0.656604:0.554534:0.656604:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Progress in Brain Research::@0.554534:0.683944:0.725577:0.683944:0.725577:0.670856:0.554534:0.670856:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 amsterdam, netherlands: :@0.725577:0.683944:0.906747:0.683944:0.906747:0.670621:0.725577:0.670621:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
elsevier;1977. 349-68.:@0.554534:0.697961:0.698724:0.697961:0.698724:0.684638:0.554534:0.684638:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
5.   Snyman Jr, ed.  antihypertensive agents. :@0.524225:0.711978:0.845120:0.711978:0.845120:0.698655:0.524225:0.698655:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Monthly :@0.848438:0.711978:0.906080:0.711978:0.906080:0.698890:0.848438:0.698890:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Index of Medical Specialities.:@0.554534:0.725995:0.737277:0.725995:0.737277:0.712907:0.554534:0.712907:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 2011;51(8):111-43.:@0.737277:0.725995:0.864277:0.725995:0.864277:0.712672:0.737277:0.712672:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
6.   Prazosin db00457 [database on the Internet].  [cited :@0.524225:0.740012:0.906713:0.740012:0.906713:0.726689:0.524225:0.726689:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
17  September  2012].  available  from:  http://www.:@0.554534:0.754029:0.903001:0.754029:0.903001:0.740706:0.554534:0.740706:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
drugbank.ca/drugs/db00457.:@0.554534:0.768046:0.755134:0.768046:0.755134:0.754723:0.554534:0.754723:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
7.   Meyers  rS, Siu  a. Pharmacotherapy review of :@0.524225:0.782063:0.906747:0.782063:0.906747:0.768740:0.524225:0.768740:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
chronic pediatric hypertension. :@0.554534:0.796080:0.768509:0.796080:0.768509:0.782757:0.554534:0.782757:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Clinical Therapeutics.:@0.767517:0.796080:0.903018:0.796080:0.903018:0.782992:0.767517:0.782992:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.903018:0.796080:0.906764:0.796080:0.906764:0.782757:0.903018:0.782757:0.000000
2011;33(10):1331-56.:@0.554534:0.810098:0.694482:0.810098:0.694482:0.796774:0.554534:0.796774:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
8.   doxazosin  db00590  [database  on  the  Internet]. :@0.524225:0.824115:0.906730:0.824115:0.906730:0.810791:0.524225:0.810791:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.902984:0.824115:0.906730:0.824115:0.906730:0.810791:0.902984:0.810791:0.000000
[cited 17 September 2012]. available from: http://:@0.554534:0.838132:0.903001:0.838132:0.903001:0.824808:0.554534:0.824808:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
www.drugbank.ca/drugs/db00590.:@0.554534:0.852149:0.794850:0.852149:0.794850:0.838825:0.554534:0.838825:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
9.   Cheng JWM.  nebivolol:  a third-generation :@0.524225:0.866166:0.906747:0.866166:0.906747:0.852842:0.524225:0.852842:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
β-blocker  for  hypertension. :@0.554534:0.880183:0.755236:0.880183:0.755236:0.866859:0.554534:0.866859:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Clinical Therapeutics.:@0.761531:0.880183:0.903018:0.880183:0.903018:0.867095:0.761531:0.867095:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.903018:0.880183:0.906764:0.880183:0.906764:0.866859:0.903018:0.866859:0.000000
2009;31(3):447-62.:@0.554534:0.894200:0.677788:0.894200:0.677788:0.880877:0.554534:0.880877:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
10.   Messerli FH, Grossman e. β-blockers in hypertension: :@0.524225:0.908217:0.906730:0.908217:0.906730:0.894894:0.524225:0.894894:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Is carvedilol different? :@0.554534:0.922234:0.720566:0.922234:0.720566:0.908911:0.554534:0.908911:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
The American Journal of :@0.727767:0.922234:0.906114:0.922234:0.906114:0.909146:0.727767:0.909146:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Cardiology.:@0.554534:0.936392:0.627775:0.936392:0.627775:0.923304:0.554534:0.923304:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 2004;93(9, Supplement 1):7-12.:@0.627775:0.936392:0.841477:0.936392:0.841477:0.923069:0.627775:0.923069:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000